摘要
Background:The sterile inflammatory response is one of the key mechanisms leading to hepatic ischemia-reperfusion injury.Melatonin has been shown to prevent organ injuries,but its roles in the inflammatory response after hepatic ischemia-reperfusion injury have not been fully explored,especially in late ischemia-reperfusion injury.The present study aimed to investigate the roles and possible mechanisms of melatonin in the inflammatory response after hepatic ischemia-reperfusion injury.Methods:Sixty Sprague-Dawley rats were randomly divided into a sham group,ischemia-reperfusion injury group(I/R group),and melatonin-treated group(M+I/R group).The rats in the I/R group were subjected to 70%hepatic ischemia for 45 min,followed by 5 or 24 h of reperfusion.The rats in the M+I/R group were injected with melatonin(10 mg/kg,intravenous injection)15 min prior to ischemia and immediately before reperfusion.Serum and samples of ischemic liver lobes were harvested for future analysis,and the 7-day survival rate was assessed after hepatic ischemia-reperfusion surgery.Results:In comparison with the I/R group,the M+I/R group showed markedly decreased expression levels of inflammatory cytokines(IL-6 and TNF-α)and numbers of apoptotic hepatocytes(P<0.05).Immunoblotting showed that the expression levels of IL-6,p-NF-κBp65/t-NF-κBp65 and p-IκB-α/t-IκB-αin the M+I/R group were significantly lower than those in the I/R group,and immunofluorescence staining showed that the expression level of p-NF-κBp65 in the M+I/R group was lower than that in the I/R group(P<0.05).The 7-day survival rates were 20%in the I/R group and 50%in the M+I/R group(P<0.05).Conclusions:Melatonin downregulated the activity of the NF-κB signaling pathway in the early and late stages of hepatic ischemia-reperfusion injury,alleviated the inflammatory response,protected the liver from ischemia-reperfusion injury,and increased the survival rate.
基金
supported by grants from the National Natural Science Foundation of China(81960123 and 81760119)
Yunnan Provincial Science and Technology Department and Kunming Medical University Collaborative Fund(2019FE001-037)。